Status:
UNKNOWN
Treatment of Asymptomatic Toxocariasis With Albendazole in Children
Lead Sponsor:
Hospital de Niños R. Gutierrez de Buenos Aires
Conditions:
Toxocariasis
Eligibility:
All Genders
2-15 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate effectiveness of albendazole in the treatment of the asymptomatic infection with the parasite Toxocara in children. Treatment response is defined as a reductio...
Eligibility Criteria
Inclusion
- Pediatric ambulatory patients with asymptomatic toxocariasis
- Children 2 - 15 years old
- Absolute eosinophil count \> 1100 / mm3
- Normal ophthalmoscopy
Exclusion
- Treatment with a benzimidazole in the previous year
- Infection by other nematodes (Ascaris lumbricoides, strongyloides stercoralis, uncinarias, Trichuris trichuria)
- Symptomatic patients (prolonged fever, acute pneumonitis, hepatomegaly, splenomegaly, ocular compromise due to toxocara)
- Concomitant diseases
- Immunocompromised patients
- Altered liver or kidney function
- Pregnancy
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2025
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00755560
Start Date
September 1 2008
End Date
July 1 2025
Last Update
March 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Parasitology Division, Children's Hospital "R Gutierrez" of Buenos Aires
Buenos Aires, Argentina, 1425